Hospital Inpatient Free Trial Program

Access to therapy when patients need it

Through the Hospital Inpatient Free Trial Program, hospitalized patients may receive up to 2 free trial units of ARISTADA® (aripiprazole lauroxil) per calendar year, subject to quantity limits. Hospital pharmacies may request free trial units of ARISTADA, and orders ship directly to your hospital. There is no requirement for subsequent use of ARISTADA for any patient receiving a free trial unit through this program.

How to participate

  1. Use the link below to go to our program site and complete the Hospital Inpatient Free Trial enrollment.
  2. Order and receive your free trial units of ARISTADA. Your order will ship directly to your hospital.*
  3. Trial an appropriate patient in the hospital with a free trial unit of ARISTADA.
  4. Order and receive your next free trial unit of ARISTADA. Only 2 free trial units of ARISTADA may be redeemed per patient.

Registration and ordering

For eligible hospital pharmacies ready to register, or if you need to reorder trial units, please visit our program site.

Go to program site

Hospital Inpatient Free Trial Program highlights

  • Available only to hospital inpatient pharmacies for use in a hospital licensed as a hospital and cannot accept PDMA-compliant samples
  • ARISTADA is being provided free of charge for appropriate hospitalized patients
  • There is no requirement for subsequent use of ARISTADA for any patient receiving a free trial unit through this program
  • Program available throughout the United States (not including its territories)
  • Limit of 2 free trial units per patient per calendar year
  • Free trial units provided under this program are commercial trade products, not samples
  • You may NOT bill the patient, the patient’s insurance carrier, or any government healthcare program for any ARISTADA dispensed as part of this program
  • You may NOT sell, trade, barter, or return for credit any ARISTADA provided as part of the program
  • Where drug costs are included in a capitated rate or there is submission of a cost report or other insurer or government program reporting requirements, you must properly report the free trial units because the ARISTADA you receive is not a sample, it is free commercial trade product

Additional limits may apply per institution. This program, as amended from time to time, will be available through December 31, 2017.

*Shipments will not be processed on holidays or pending inclement weather. These factors may result in a delay in shipment.

Alkermes, Inc. may terminate the program prior to December 31, 2017, upon 60 days’ notice to all participating inpatient pharmacies, or upon less or no notice if there is a change in interpretation of federal or state laws supporting the continuation of this program.